CN106563117A - 用于治疗病毒性肺炎的药物及其方法和装置 - Google Patents
用于治疗病毒性肺炎的药物及其方法和装置 Download PDFInfo
- Publication number
- CN106563117A CN106563117A CN201611014459.2A CN201611014459A CN106563117A CN 106563117 A CN106563117 A CN 106563117A CN 201611014459 A CN201611014459 A CN 201611014459A CN 106563117 A CN106563117 A CN 106563117A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- viral pneumonia
- medicine
- smoke evacuation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 67
- 206010035737 Pneumonia viral Diseases 0.000 title claims abstract description 45
- 208000009421 viral pneumonia Diseases 0.000 title claims abstract description 45
- 229940079593 drug Drugs 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 13
- 240000007594 Oryza sativa Species 0.000 claims abstract description 19
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 19
- 241000054262 Cassytha capillaris Species 0.000 claims abstract description 18
- 244000075440 Catunaregam spinosa Species 0.000 claims abstract description 17
- 229940036811 bone meal Drugs 0.000 claims abstract 2
- 239000002374 bone meal Substances 0.000 claims abstract 2
- 235000013599 spices Nutrition 0.000 claims description 49
- 239000000843 powder Substances 0.000 claims description 48
- 239000000779 smoke Substances 0.000 claims description 30
- 230000007246 mechanism Effects 0.000 claims description 27
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 18
- 241000237636 Pheretima Species 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 238000005520 cutting process Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 8
- 239000011812 mixed powder Substances 0.000 claims description 8
- 239000003973 paint Substances 0.000 claims description 8
- 239000002966 varnish Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 5
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 5
- 239000011425 bamboo Substances 0.000 claims description 5
- 239000011324 bead Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 230000033001 locomotion Effects 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 238000007790 scraping Methods 0.000 claims description 3
- 244000294611 Punica granatum Species 0.000 claims 2
- 235000014360 Punica granatum Nutrition 0.000 claims 2
- 244000082204 Phyllostachys viridis Species 0.000 claims 1
- 230000008450 motivation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 206010008479 Chest Pain Diseases 0.000 abstract description 4
- 206010037660 Pyrexia Diseases 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000448204 Ajuga nipponensis Species 0.000 abstract 1
- 241000005787 Cistanche Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 244000235659 Rubus idaeus Species 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 229910052891 actinolite Inorganic materials 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 235000013339 cereals Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000010903 husk Substances 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 15
- 235000010894 Artemisia argyi Nutrition 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 9
- 206010035664 Pneumonia Diseases 0.000 description 9
- 244000030166 artemisia Species 0.000 description 9
- 230000000857 drug effect Effects 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 206010020741 Hyperpyrexia Diseases 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000010659 mugwort oil Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 206010036790 Productive cough Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 241001330002 Bambuseae Species 0.000 description 4
- 241000709661 Enterovirus Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002085 persistent effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 241000701022 Cytomegalovirus Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 206010044302 Tracheitis Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- -1 decoction Substances 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000003517 fume Substances 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 206010037833 rales Diseases 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 206010006448 Bronchiolitis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 206010014978 Epidemic pleurodynia Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 201000006219 Herpangina Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000027685 extreme exhaustion Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000010707 pulmonary consolidation Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000030925 respiratory syncytial virus infectious disease Diseases 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明用于治疗病毒性肺炎的药物,其由以下重量份组成:糯米30‑50份,五谷皮20‑35份,查干告亚14‑28份,三角藤12‑29份,无根草18‑28份,乌藨子13‑23份,阳起石17‑22份,淫羊藿15‑25份,山石榴19‑21份,白九重楼11‑29份,红景天13‑26份,花椒6‑8份,生姜5‑9份,济州岛五味子7‑10份,地龙4‑6份,马骨粉3‑5份,蛇胆2‑5份,蟾衣3‑5份,玛卡酰胺1份。本发明利用中药和中药提取物玛卡酰胺的作用,对于病毒性肺炎有极佳的效果,能够补气、养肾、益经、活血、消除病毒性肺炎带来的高烧持续不退、胸闷、气喘的现象,并且治疗效果远好于传统的中药和西药。
Description
技术领域
本发明涉及一种药物,特别是涉及一种用于治疗病毒性肺炎的药物。
背景技术
病毒性肺炎是由上呼吸道病毒感染、向下蔓延所致的肺部炎症。本病一年四季均可发生,但大多见于冬春季节,可暴发或散发流行。临床主要表现为发热、头痛、全身酸痛、持续高烧不退等,使用抗生素、干扰素治疗无明显疗效。病毒性肺炎的发生与病毒的毒力、感染途径以及宿主的年龄、免疫功能状态等有关。一般小儿发病率高于成人。
急性呼吸道感染中,病毒感染占90%,而病毒感染则以上呼吸道为主,有普通感冒、咽炎、喉-气管-支气管炎、细支气管炎、婴儿疱疹性咽峡炎以及流行性胸痛等。引起肺炎的病毒不多见,其中以流行性感冒病毒为常见,其他为副流感病毒、巨细胞病毒、腺病毒、鼻病毒、冠状病毒和某些肠道病毒,如柯萨奇、埃可病毒等,以及单纯疱疹、水痘-带状疱疹、风疹、麻疹等病毒。婴幼儿还常由呼吸道合胞病毒感染产生肺炎。病毒性肺炎多发生于冬春季节,可散发流行或暴发。在非细菌性肺炎中,病毒感染占25%~50%,患者多为儿童,成人相对少见。
近年来由于免疫抑制药物广泛应用于肿瘤、器官移植,以及艾滋病的发病人数逐年增多等,单纯疱疹病毒、水痘-带状疱疹病毒、巨细胞病毒等,都可引起严重的肺炎。病毒性肺炎为吸入性感染,通过人与人的飞沫传染,主要是由上呼吸道病毒感染向下蔓延所致,常伴气管-支气管炎,家畜如马、猪等有时带有某种流行性感冒病毒,偶见接触传染。粪经口传染见于肠道病毒,呼吸道合胞病毒通过尘埃传染。器官移植的病例可以通过多次输血,甚至供者的器官引起病毒。血行播散的病毒性肺炎并不伴气管-支气管炎。
本病临床表现一般较轻,与支原体肺炎的症状相似。起病缓慢,有头痛、乏力、高烧持续不退。体征往往缺如。X线检查肺部炎症呈斑点状、片状或均匀的阴影。白细胞总数可正常、减少或略增加。病程一般为1~2周。在免疫缺损的患者,病毒性肺炎往往比较严重,有持续性高热、心悸、气急、发绀、极度衰竭,可伴休克、心力衰竭和氮质血症。由于肺泡间质和肺泡内水肿,严重者可发生呼吸窘迫综合征。体检可有湿啰音。X线检查显示弥漫性结节性浸润,多见于两下2/3肺野。
发明内容
本发明要解决的技术问题是提供一种结构简单、成本低、操作简便的用于治疗病毒性肺炎的药物。
本发明用于治疗病毒性肺炎的药物,其由以下重量份组成:糯米30-50份,五谷皮20-35份,查干告亚14-28份,三角藤12-29份,无根草18-28份,乌藨子13-23份,阳起石17-22份,淫羊藿15-25份,山石榴19-21份,白九重楼11-29份,红景天13-26份,花椒6-8份,生姜5-9份,济州岛五味子7-10份,地龙4-6份,马骨粉3-5份,蛇胆2-5份,蟾衣3-5份,玛卡酰胺1份。
本发明用于治疗病毒性肺炎的药物,其中所述糯米45份,五谷皮28份,查干告亚25份,三角藤20份,无根草25份,乌藨子18份,阳起石19份,淫羊藿16份,山石榴20份,白九重楼14份,红景天19份,花椒7份,生姜8份,济州岛五味子8份,地龙5份,马骨粉4份,蛇胆3份,蟾衣4份,玛卡酰胺1份。
本发明制备权利要求1所述的用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用纱布包裹上述研磨成的粉末,形成第一中药料包,然后将中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用纱布包裹,形成第二中药料包;
(3)提取:加入其重量2-5倍的水煎煮4-6次,每次4~6小时,每次煎煮后过滤,合并滤液并减压浓缩至相对密度为2.10-2.15的浸膏,再加入乙醇至含醇量为40-50%,静置后过滤,滤液减压回收乙醇并浓缩至相对密度为2.15-2.25的浸膏,然后加入等量的正丁醇,萃取2-3次,收集萃取液,回收正丁醇并将萃取液浓缩至比重为2.25-2.30的浸膏,最后干燥即得中药取物。
本发明制备权利要求1所述的用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用竹叶包裹上述研磨成的粉末,形成第一中药料包;然后将第一中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用竹叶包裹,形成第二中药料包;
(3)上艾油:将第二中药料包的外层利用燃烧艾灸熏烤30-60min;
(4)烤制:在真空的条件下,将熏烤后的第二中药料包放入竹筒中烤制30-60min;
(5)粉碎:将第二中药料包打碎成粉末。
本发明制备权利要求4所述的用于治疗病毒性肺炎的药物的装置,包括外壳、半球斗、排烟柱、周向旋转机构、曲柄滑块机构、集油槽、水平晃动部;
所述外壳的底部设有进烟口,所述进沿口的上侧设有正圆台形的凸台,所述凸台的上侧设有半球斗,所述半球斗的下侧设有开口,所述半球斗的内部设有第二中药料包;半球斗的上部与排烟柱连接,所述排烟柱的顶部通过曲柄滑块机构与外壳的顶部固定,所述曲柄滑块机构包括曲轴、连杆、滑块、导柱、第一电机,所述第一电机和导柱与所述外壳的顶部固定,所述第一电机的输出轴与所述曲轴的一端固定,所述曲轴的另一端与所述连杆的一端铰链连接,所述连杆的另一端与滑块铰链连接,所述滑块沿导柱导向移动,所述滑块与所述排烟柱固定连接,所述排烟柱的顶部设有伞状网,所述伞状网的外端设有集油槽,所述滑块的外表面设有刮油刷,所述刮油刷的端部沿所述集油槽的内表面移动;
所述滑块通过周向旋转机构与所述排烟柱固定,所述周向旋转机构包括棘轮、齿条、齿轮、第二电机、轴承,所述滑块的下侧通过轴承安装排烟柱,所述滑块的外表面固定有第二电机,所述第二电机的输出轴设有齿轮,所述齿轮与齿条啮合,所述齿条的一端与所述棘轮的外圈铰链连接,所述棘轮的内圈与所述排烟柱的外圆周面固定;
所述外壳的位于所述排烟柱的一侧设有水平晃动机构,所述水平晃动机构包括第三电机、凸轮,所述第三电机与所述外壳的内表面固定,所述第三电机的输出轴设有凸轮,所述凸轮的端部与所述排烟柱接触。
本发明通过上述机构可在半球斗内对于第二中药料包进行周向转动、水平方向晃动、上下方向晃动,从而使第二中药料包的外表面可均匀地受到艾烟的均匀熏烤,避免第二中药料包中的某一个点受到集中的加热而出现烤糊的现象。并且,所述在曲柄滑块机构和集油槽之间设有刮油刷,可对于收集到的油,继续转化成油气,从而使艾油的利用效率更高,第二中药料包中的艾油包裹性更好。
本发明用于治疗病毒性肺炎的药物与现有技术不同之处在于本发明用于治疗病毒性肺炎的药物利用中药和中药提取物玛卡酰胺的作用,对于病毒性肺炎有极佳的效果,能够补气、养肾、益经、活血、消除病毒性肺炎带来的高烧持续不退、胸闷、气喘的现象,并且治疗效果远好于传统的中药和西药。
其中糯米:有补中益气、健脾养胃、止虚汗的功效。
五谷皮:祛风湿,补益肝肾,强筋壮骨,利水消肿。
枸杞皮:退热除蒸。
查干告亚:补肾阳、益精血、润肠道。
三角藤:补气养血,易经活络。
无根草:滋补肝肾、固精缩尿、安胎、明目、止泻之功效。
乌藨子:益肾固精缩尿,养肝明目之功效。
阳起石:温肾壮阳。
淫羊藿:补命门、益精气、强筋骨、补肾壮阳之要药。
山石榴:固精缩尿、固崩止带、涩肠止泻。
白九重楼:清肺止咳,利胆退黄,凉肝息风,软坚散结。
红景天:补气清肺,益智养心。
花椒:促进唾液分泌,使血管扩张。
生姜:发散、止呕、止咳。
济州岛五味子:收敛固涩、益气生津、补肾宁心。
地龙:清热定惊、通络、平喘、利尿。
马骨粉:止邪疟。
蛇胆:散瘀、化积、解毒。
蟾衣:息风镇痉,通络止痛,攻毒散结。
玛卡酰胺:促进荷尔蒙分泌。
本发明认为,病毒性肺炎是由于气血两亏、劳累过度引发的上呼吸道的病变,此时内虚且外部的副流感病毒、巨细胞病毒、腺病毒、鼻病毒、冠状病毒和某些肠道病毒入侵呼吸系统才会导致发病。其病理变化常常表现出以肺虚为本,感受外邪,跌扑闪挫为标的特点。故治疗本病多以补肾益气、活血通络为主。方中糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天,能够温润通络、气血双补,合为君。花椒、生姜、济州岛五味子、地龙、马骨粉,能够调节阴阳,合为臣。蛇胆、蟾衣,能够以毒攻毒,合为佐。玛卡酰胺能够通过刺激荷尔蒙的分泌、提高免疫力,从而抵抗蛇胆、蟾衣中的毒性,并且发挥上述方中的药性,故为使。
本发明药方中以大量补肾益气、活血通络、固精温润的药剂为主,且主治病毒性肺炎。本发明以经验理论为本,结合现代技术提取出的玛卡中的玛卡酰胺作为药引,可去除蛇胆、蟾衣中的毒性而保留其药效。本药方在多年治疗病毒性肺炎中所总结的精华药方,对于治疗病毒性肺炎取得了丰硕的成果。本发明选用中药成分和天然提取物玛卡酰胺,用于治疗病毒性肺炎见效快,疗效确切、无副作用、成本低、疗程短、治愈率高的特点。
下面结合附图对本发明的用于治疗病毒性肺炎的药物作进一步说明。
附图说明
图1是制备用于治疗病毒性肺炎的药物的装置的示意图。
具体实施方式
一、中药组合物的制备:
实施例1
本发明用于治疗病毒性肺炎的药物,其由以下成分组成:糯米45份,五谷皮28份,查干告亚25份,三角藤20份,无根草25份,乌藨子18份,阳起石19份,淫羊藿16份,山石榴20份,白九重楼14份,红景天19份,花椒7份,生姜8份,济州岛五味子8份,地龙5份,马骨粉4份,蛇胆3份,蟾衣4份,玛卡酰胺1份。
制备用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用纱布包裹上述研磨成的粉末,形成第一中药料包,然后将中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用纱布包裹,形成第二中药料包;
(3)提取:加入其重量2-5倍的水煎煮4-6次,每次4~6小时,每次煎煮后过滤,合并滤液并减压浓缩至相对密度为2.10-2.15的浸膏,再加入乙醇至含醇量为40-50%,静置后过滤,滤液减压回收乙醇并浓缩至相对密度为2.15-2.25的浸膏,然后加入等量的正丁醇,萃取2-3次,收集萃取液,回收正丁醇并将萃取液浓缩至比重为2.25-2.30的浸膏,最后干燥即得中药取物。
本发明通过上述方式可将药物中的有效成分提纯萃取,从而使药物的药效得到充分的发挥,并且,上述中药提取物的保质期更久,药效衰退更弱。
上述中药提取物可根据患者的需要制备丸药、口服液、汤药、胶囊剂、颗粒剂、片剂。
实施例2
本发明用于治疗病毒性肺炎的药物,其由以下成分组成:糯米45份,五谷皮28份,查干告亚25份,三角藤20份,无根草25份,乌藨子18份,阳起石19份,淫羊藿16份,山石榴20份,白九重楼14份,红景天19份,花椒7份,生姜8份,济州岛五味子8份,地龙5份,马骨粉4份,蛇胆3份,蟾衣4份,玛卡酰胺1份。
制备用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用竹叶包裹上述研磨成的粉末,形成第一中药料包;然后将第一中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用竹叶包裹,形成第二中药料包;
(3)上艾油:将第二中药料包的外层利用燃烧艾灸熏烤30-60min;
(4)烤制:在真空的条件下,将熏烤后的第二中药料包放入竹筒中烤制30-60min;
(5)粉碎:将第二中药料包打碎成粉末。
本发明通过上述艾灸中的艾烟中的艾油和竹叶将第二中药料包封装起来,从而保障其加热时的药效不会挥发出去,并且,再利用烤制的方式代替传统的文武火煎煮草药,从而在加热药物、发挥药效的同时,最大限度地隔绝药物与外界的联系,从而封存药效,使药效效果更好。
上述粉末状的中药可根据患者的需要制备丸药、口服液、汤药、胶囊剂、颗粒剂、片剂。
实施例3
本发明用于治疗病毒性肺炎的药物,其由以下成分组成:糯米30份,五谷皮20份,查干告亚14份,三角藤12份,无根草18份,乌藨子13份,阳起石17份,淫羊藿15份,山石榴19份,白九重楼11份,红景天13份,花椒6份,生姜5份,济州岛五味子7份,地龙4份,马骨粉3份,蛇胆2份,蟾衣3份,玛卡酰胺1份。
制备用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用竹叶包裹上述研磨成的粉末,形成第一中药料包;然后将第一中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用竹叶包裹,形成第二中药料包;
(3)上艾油:将第二中药料包的外层利用燃烧艾灸熏烤30-60min;
(4)烤制:在真空的条件下,将熏烤后的第二中药料包放入竹筒中烤制30-60min;
(5)粉碎:将第二中药料包打碎成粉末。
本发明通过上述艾灸中的艾烟中的艾油和竹叶将第二中药料包封装起来,从而保障其加热时的药效不会挥发出去,并且,再利用烤制的方式代替传统的文武火煎煮草药,从而在加热药物、发挥药效的同时,最大限度地隔绝药物与外界的联系,从而封存药效,使药效效果更好。
上述粉末状的中药可根据患者的需要制备丸药、口服液、汤药、胶囊剂、颗粒剂、片剂。
实施例4
本发明用于治疗病毒性肺炎的药物,其由以下成分组成:糯米45份,五谷皮28份,查干告亚25份,三角藤20份,无根草25份,乌藨子18份,阳起石19份,淫羊藿16份,山石榴20份,白九重楼14份,红景天19份,花椒7份,生姜8份,济州岛五味子8份,地龙5份,马骨粉4份,蛇胆3份,蟾衣4份,玛卡酰胺1份。
制备用于治疗病毒性肺炎的药物的方法,包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用竹叶包裹上述研磨成的粉末,形成第一中药料包;然后将第一中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用竹叶包裹,形成第二中药料包;
(3)上艾油:将第二中药料包的外层利用燃烧艾灸熏烤30-60min;
(4)烤制:在真空的条件下,将熏烤后的第二中药料包放入竹筒中烤制30-60min;
(5)粉碎:将第二中药料包打碎成粉末。
参见图1,在上述实施例4中艾油的步骤中,采用治疗病毒性肺炎的药物的装置,即将第二中药料包包裹艾油的装置,包括外壳401、半球斗404、排烟柱405、周向旋转机构406、曲柄滑块机构408、集油槽409、水平晃动部410;
所述外壳401的底部设有进烟口402,所述进沿口402的上侧设有正圆台形的凸台403,所述凸台403的上侧设有半球斗404,所述半球斗404的下侧设有开口,所述半球斗404的内部设有第二中药料包;半球斗404的上部与排烟柱405连接,所述排烟柱405的顶部通过曲柄滑块机构408与外壳401的顶部固定,所述曲柄滑块机构408包括曲轴、连杆、滑块、导柱、第一电机,所述第一电机和导柱与所述外壳401的顶部固定,所述第一电机的输出轴与所述曲轴的一端固定,所述曲轴的另一端与所述连杆的一端铰链连接,所述连杆的另一端与滑块铰链连接,所述滑块沿导柱导向移动,所述滑块与所述排烟柱405固定连接,所述排烟柱405的顶部设有伞状网407,所述伞状网407的外端设有集油槽409,所述滑块的外表面设有刮油刷,所述刮油刷的端部沿所述集油槽409的内表面移动;
所述滑块通过周向旋转机构406与所述排烟柱405固定,所述周向旋转机构406包括棘轮、齿条、齿轮、第二电机、轴承,所述滑块的下侧通过轴承安装排烟柱405,所述滑块的外表面固定有第二电机,所述第二电机的输出轴设有齿轮,所述齿轮与齿条啮合,所述齿条的一端与所述棘轮的外圈铰链连接,所述棘轮的内圈与所述排烟柱405的外圆周面固定;
所述外壳401的位于所述排烟柱405的一侧设有水平晃动机构410,所述水平晃动机构包括第三电机、凸轮,所述第三电机与所述外壳401的内表面固定,所述第三电机的输出轴设有凸轮,所述凸轮的端部与所述排烟柱接触。本发明通过上述机构可在半球斗404内对于第二中药料包进行周向转动、水平方向晃动、上下方向晃动,从而使第二中药料包的外表面可均匀地受到艾烟的均匀熏烤,避免第二中药料包中的某一个点受到集中的加热而出现烤糊的现象。并且,所述在曲柄滑块机构和集油槽之间设有刮油刷,可对于收集到的油,继续转化成油气,从而使艾油的利用效率更高,第二中药料包中的艾油包裹性更好。
二、药效实施例
为进一步说明本发明的中药组合物的效果,利用实施例2和实施例4制备的颗粒剂对病毒性肺炎患者进行治疗。
本发明制备的用于治疗病毒性肺炎的药物主要用于病毒性肺炎,其症状参照国家中医药管理局颁布的《中医病证诊断及疗效标准》得出以下结论。
一、临床资料
1、一般资料
(1)病史及发病特点:起病急,传变快,病程短,四季发病,以冬春多见。
(2)临床表现:发病初起,发热重恶寒轻、高烧持续不退、头痛、舌边尖红、苔薄黄或黄白相兼、脉浮数,或高热烦渴、咳喘胸痛、咯痰色黄或带血丝、舌红苔黄或腻、脉滑数。
(3)主要体征:肺部局部叩诊可有浊音,听诊呼吸音降低或有湿罗音,或有支气管呼吸音。
(4)主要辅助检查:肺部X线可有炎性改变;血常规:白细胞总数或中性增多。
2、诊断标准
(1)新近出现的持续高烧不退,或原有呼吸道疾病症状加重,并出现脓性痰;伴或不伴胸痛。
(2)发热。
(3)肺实变体征和(或)湿性啰音。
(4)WBC>10×109/L或<4×109/L,伴或不伴核左移。
(5)胸部X线检查显示片状、斑片状浸润性阴影或间质性改变,伴或不伴胸腔积液。
3、证候诊断
参照中华人民共和国中医药行业标准《中医病证诊断疗效标准》。
1.邪犯肺卫证:发热重,恶寒轻,咳嗽痰白、口微渴,头痛,鼻塞;舌边尖红,苔薄白或微黄,脉浮数。
2.痰热壅肺证:高热不退,咳痰黄稠或咳铁锈色痰,胸痛,呼吸气促,口渴烦躁,小便黄赤,伴见大便干燥或便秘,舌红苔黄,脉洪数或滑数。
3.痰浊阻肺证:咳声重浊,胸闷,咯白粘痰,伴有疲倦纳呆,腹胀,大便溏,舌淡红,苔白腻,脉滑。
4.正虚邪恋证:干咳少痰,口燥咽干,腹胀,神倦纳差;舌淡红苔白腻,脉细滑。
二、研究方法
将300例患者来源于北京协和医院,均为2006年8月至2010年6月收治的处于病毒性肺炎的患者,按上述诊断标准纳入,随机分三组。治疗组按照实施例2或实施例4的方式每日复用颗粒剂,一日两次,7天为一个疗程。对照组继续使用传统药物治疗。若患者在评定疗效前痊愈,则提前终止治疗。
三、疗效评定标准
根据《临床常见疾病诊疗标准》对治疗后的患者进行疗效评定。
痊愈:临床症状全部消失,试验室检查正常;好转:临床症状减轻,实验室检查改善或正常;无效:临床症状无明显好转或加重。
数据处理和统计
表1是采用实施例2或实施例4的治疗组与对照组的疗效结果比较
组别 | 痊愈 | 显效 | 好转 | 无效 | 总有效 |
治疗组1 | 30(30%) | 23(43%) | 32(32%) | 15(15%) | 85(85%) |
治疗组2 | 48(48%) | 20(20%) | 28(28%) | 6(6%) | 94(94%) |
对照组97 | 25(22.7%) | 23(23.7%) | 27(27.8%) | 22(22.7%) | 75(77.3%) |
表2是采用实施例2的治疗组与对照组的具体效果比较
每日咳嗽次数 | 每日咳痰 | 每日气喘次数 | 每日胸闷次数 | 每日气喘次数 | |
治疗组1 | 1.5次 | 1.9ml | 1.2次 | 0.9次 | 1.4次 |
治疗组2 | 0.6次 | 0.8ml | 0.9次 | 0.5次 | 0.7次 |
对照组 | 15次 | 10ml | 5.1次 | 3.2次 | 4.9次 |
可见,本发明所述药物,在对于病毒性肺炎患者的治疗上,相对于传统治疗方法,具有明显改善,同时,在制备药物过程中,采用本发明装置进一步制备成药物后,其改善效果更佳,相对于常规制备方法,提取效率更高,药物疗效更好。
四、具体病历
病例1:王某,女,6岁,山东人。已经确诊病毒性肺炎2个月,高烧持续不退、痰多日益加重,且伴有呼吸异响、肺部憋闷的情况,使用抗生素、干扰素治疗无明显疗效。使用本发明的疗法后,利用上述颗粒剂早晚各服一次,持续两个疗程,患者退烧,咳痰明显减少,呼吸无异响,连续四个疗程后,病情得到痊愈。
病例2:赵某某,男,10岁,甘肃人。已经确诊病毒性肺炎1周,生活环境风沙较大,工作空气质量差,且与肺病患者同居,使用抗生素、干扰素治疗无明显疗效。使用本发明的疗法后,上述症状明显好转,在使用四个疗程的颗粒剂后病情痊愈,回访未复发。
以上所述的实施例仅仅是对本发明的优选实施方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案作出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。
Claims (5)
1.一种用于治疗病毒性肺炎的药物,其由以下重量份组成:
糯米30-50份,五谷皮20-35份,查干告亚14-28份,三角藤12-29份,无根草18-28份,乌藨子13-23份,阳起石17-22份,淫羊藿15-25份,山石榴19-21份,白九重楼11-29份,红景天13-26份,花椒6-8份,生姜5-9份,济州岛五味子7-10份,地龙4-6份,马骨粉3-5份,蛇胆2-5份,蟾衣3-5份,玛卡酰胺1份。
2.根据权利要求1所述的用于治疗病毒性肺炎的药物,其特征在于:所述糯米45份,五谷皮28份,查干告亚25份,三角藤20份,无根草25份,乌藨子18份,阳起石19份,淫羊藿16份,山石榴20份,白九重楼14份,红景天19份,花椒7份,生姜8份,济州岛五味子8份,地龙5份,马骨粉4份,蛇胆3份,蟾衣4份,玛卡酰胺1份。
3.制备权利要求1所述的用于治疗病毒性肺炎的药物的方法,其特征在于包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用纱布包裹上述研磨成的粉末,形成第一中药料包,然后将中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用纱布包裹,形成第二中药料包;
(3)提取:加入其重量2-5倍的水煎煮4-6次,每次4~6小时,每次煎煮后过滤,合并滤液并减压浓缩至相对密度为2.10-2.15的浸膏,再加入乙醇至含醇量为40-50%,静置后过滤,滤液减压回收乙醇并浓缩至相对密度为2.15-2.25的浸膏,然后加入等量的正丁醇,萃取2-3次,收集萃取液,回收正丁醇并将萃取液浓缩至比重为2.25-2.30的浸膏,最后干燥即得中药取物。
4.制备权利要求1所述的用于治疗病毒性肺炎的药物的方法,其特征在于包括如下步骤:
(1)打粉:将上述糯米、五谷皮、查干告亚、三角藤、无根草、乌藨子、阳起石、淫羊藿、山石榴、白九重楼、红景天、花椒、生姜、济州岛五味子、地龙、蛇胆、蟾衣采用清水洗净,烘干后,进行切段放入研磨器中研磨成粉末,
(2)打包:采用竹叶包裹上述研磨成的粉末,形成第一中药料包;然后将第一中药料包的外层包裹马骨粉和玛卡酰胺的混合粉末,再采用竹叶包裹,形成第二中药料包;
(3)上艾油:将第二中药料包的外层利用燃烧艾灸熏烤30-60min;
(4)烤制:在真空的条件下,将熏烤后的第二中药料包放入竹筒中烤制30-60min;
(5)粉碎:将第二中药料包打碎成粉末。
5.制备权利要求4所述的用于治疗病毒性肺炎的药物的装置,其特征在于:包括外壳(401)、半球斗(404)、排烟柱(405)、周向旋转机构(406)、曲柄滑块机构(408)、集油槽(409)、水平晃动部(410);
所述外壳(401)的底部设有进烟口(402),所述进沿口(402)的上侧设有正圆台形的凸台(403),所述凸台(403)的上侧设有半球斗(404),所述半球斗(404)的下侧设有开口,所述半球斗(404)的内部设有第二中药料包;半球斗(404)的上部与排烟柱(405)连接,所述排烟柱(405)的顶部通过曲柄滑块机构(408)与外壳(401)的顶部固定,所述曲柄滑块机构(408)包括曲轴、连杆、滑块、导柱、第一电机,所述第一电机和导柱与所述外壳(401)的顶部固定,所述第一电机的输出轴与所述曲轴的一端固定,所述曲轴的另一端与所述连杆的一端铰链连接,所述连杆的另一端与滑块铰链连接,所述滑块沿导柱导向移动,所述滑块与所述排烟柱(405)固定连接,所述排烟柱(405)的顶部设有伞状网(407),所述伞状网(407)的外端设有集油槽(409),所述滑块的外表面设有刮油刷,所述刮油刷的端部沿所述集油槽(409)的内表面移动;
所述滑块通过周向旋转机构(406)与所述排烟柱(405)固定,所述周向旋转机构(406)包括棘轮、齿条、齿轮、第二电机、轴承,所述滑块的下侧通过轴承安装排烟柱(405),所述滑块的外表面固定有第二电机,所述第二电机的输出轴设有齿轮,所述齿轮与齿条啮合,所述齿条的一端与所述棘轮的外圈铰链连接,所述棘轮的内圈与所述排烟柱(405)的外圆周面固定;
所述外壳(401)的位于所述排烟柱(405)的一侧设有水平晃动机构(410),所述水平晃动机构包括第三电机、凸轮,所述第三电机与所述外壳(401)的内表面固定,所述第三电机的输出轴设有凸轮,所述凸轮的端部与所述排烟柱接触。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611014459.2A CN106563117A (zh) | 2016-11-15 | 2016-11-15 | 用于治疗病毒性肺炎的药物及其方法和装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611014459.2A CN106563117A (zh) | 2016-11-15 | 2016-11-15 | 用于治疗病毒性肺炎的药物及其方法和装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106563117A true CN106563117A (zh) | 2017-04-19 |
Family
ID=58542193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611014459.2A Withdrawn CN106563117A (zh) | 2016-11-15 | 2016-11-15 | 用于治疗病毒性肺炎的药物及其方法和装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106563117A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111759880A (zh) * | 2020-06-09 | 2020-10-13 | 广东金骏康生物技术有限公司 | 淫羊藿药材提取物及其在预防或治疗冠状病毒中的应用 |
CN114177171A (zh) * | 2020-09-14 | 2022-03-15 | 四川省中医药转化医学中心 | 花椒在制备治疗和/或预防呼吸道病毒肺炎的药物中的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225338A (zh) * | 2014-10-04 | 2014-12-24 | 李淑梅 | 一种治疗病毒性肺炎的药物及制备方法 |
-
2016
- 2016-11-15 CN CN201611014459.2A patent/CN106563117A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225338A (zh) * | 2014-10-04 | 2014-12-24 | 李淑梅 | 一种治疗病毒性肺炎的药物及制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111759880A (zh) * | 2020-06-09 | 2020-10-13 | 广东金骏康生物技术有限公司 | 淫羊藿药材提取物及其在预防或治疗冠状病毒中的应用 |
CN114177171A (zh) * | 2020-09-14 | 2022-03-15 | 四川省中医药转化医学中心 | 花椒在制备治疗和/或预防呼吸道病毒肺炎的药物中的用途 |
CN114177171B (zh) * | 2020-09-14 | 2023-09-22 | 四川省中医药转化医学中心 | 花椒在制备治疗和/或预防呼吸道病毒肺炎的药物中的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205042B (zh) | 一种治疗咳嗽型小儿流行性感冒的中药制备方法 | |
CN101983675A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN103263531B (zh) | 一种治疗三叉神经痛的中药组合物及其制备方法 | |
CN104147572A (zh) | 感冒发热疏风散热制剂及制备方法 | |
CN104013868A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN106563117A (zh) | 用于治疗病毒性肺炎的药物及其方法和装置 | |
CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
CN104127751A (zh) | 一种治疗痰湿犯肺型慢性支气管炎的中药及制备方法 | |
CN104147194A (zh) | 一种治疗慢性鼻窦炎的中药组合物 | |
CN103479932A (zh) | 一种治疗支气管炎的中药组合物及其制备方法 | |
CN105343274A (zh) | 一种具有消炎止咳作用的药物组合物 | |
CN105327182A (zh) | 一种治疗儿童百日咳的药物及其制备方法 | |
CN103961579A (zh) | 一种用于治疗慢性支气管炎的中药及其制备方法 | |
CN105169111A (zh) | 一种用于治疗慢性荨麻疹的中药组合物及其应用 | |
CN105288285A (zh) | 一种用于治疗慢性支气管炎的药物制剂 | |
CN105288372A (zh) | 一种治疗原发性痛经伴痤疮的药物制剂 | |
CN105055702A (zh) | 一种用于治疗慢性盆腔炎的药物制剂 | |
CN104491331B (zh) | 一种具有止咳作用的药物组合物 | |
CN105169329A (zh) | 小儿腹痛宁脐贴及其制备方法 | |
CN104606465A (zh) | 一种治疗急性咽炎的药物及其制备方法 | |
CN104645233A (zh) | 一种治疗乳腺增生的中药制剂 | |
CN104117046B (zh) | 一种治疗急性支气管炎的中药冲剂的制备方法 | |
CN104435133A (zh) | 一种退烧药 | |
CN114917287A (zh) | 一种治疗过敏性哮喘的中药组合物,其制备方法和应用 | |
CN102764347A (zh) | 一种治疗感冒及其并发症的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170419 |